|
PAK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.795360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.237410E-01 |
| Normal-vs-Stage2 |
7.648400E-01 |
| Normal-vs-Stage3 |
3.911200E-01 |
| Normal-vs-Stage4 |
2.276200E-01 |
| Stage1-vs-Stage2 |
1.268800E-01 |
| Stage1-vs-Stage3 |
5.820200E-01 |
| Stage1-vs-Stage4 |
9.461400E-01 |
| Stage2-vs-Stage3 |
3.148400E-01 |
| Stage2-vs-Stage4 |
1.860980E-01 |
| Stage3-vs-Stage4 |
6.567400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.495560E-01 |
| Normal-vs-AfricanAmerican |
6.084200E-02 |
| Normal-vs-Asian |
3.823600E-01 |
| Caucasian-vs-AfricanAmerican |
2.986400E-01 |
| Caucasian-vs-Asian |
8.591400E-01 |
| AfricanAmerican-vs-Asian |
2.918000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.659600E-01 |
| Normal-vs-Female |
1.899970E-01 |
| Male-vs-Female |
9.780600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.896200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.298000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.566600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.734600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.422070E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.201020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.011800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.382800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.802200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.328400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.130600E-01 |
| Classical-VS-Follicular |
6.03900000006874E-07 |
| Classical-VS-Other |
1.719770E-01 |
| Classical-VS-Normal |
1.421630E-02 |
| Tall-VS-Follicular |
8.386400E-04 |
| Tall-VS-Other |
1.489560E-01 |
| Tall-VS-Normal |
4.798400E-02 |
| Follicular-VS-Other |
7.943600E-01 |
| Follicular-VS-Normal |
8.613800E-02 |
| Other-VS-Normal |
5.667400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.038600E-01 |
| Normal-vs-N1 |
4.750600E-01 |
| N0-vs-N1 |
2.760200E-01 |
|
|
